COMMUNIQUÉS West-GlobeNewswire

Green Water Labs to Host Community Clean-Up Event in Celebration of Earth Day 2024

24/04/2024 - 00:23

SEATTLE, April 23, 2024 (GLOBE NEWSWIRE) -- Green Water Labs, the biochemical division of Planted Materials and provider of eco-friendly algae cleaning solutions, today announced its upcoming community clean-up event to [...]

BioSyent to Attend Planet MicroCap Showcase

23/04/2024 - 23:45

MISSISSAUGA, Ontario, April 23, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30 th [...]

Smart for Life Announces the Successful Completion of Restructuring Program

23/04/2024 - 23:30

Program Resulted in Improvement in Operations through Material Loss Reductions and Transformation of the Company’s Balance Sheet; Company Provides Update on Timing for Form 10-K MIAMI, April 23, 2024 (GLOBE NEWSWIRE [...]

FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements

23/04/2024 - 23:00

Reaffirms commitment to regaining compliance with the NYSE American continued listing standards MINNEAPOLIS, MN, April 23, 2024 (GLOBE NEWSWIRE) -- On April 17, 2024, FOXO Technologies Inc., a Delaware corporation(the [...]

Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call

23/04/2024 - 22:30

MALVERN, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who [...]

Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference

23/04/2024 - 22:30

SUNNYVALE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in [...]

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares

23/04/2024 - 22:17

BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for [...]

Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

23/04/2024 - 22:15

GARDNER, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, today [...]

OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K

23/04/2024 - 22:15

ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company [...]

Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

23/04/2024 - 22:15

GAITHERSBURG, Md., April 23, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer [...]

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024

23/04/2024 - 22:05

FRANKLIN, Tenn., April 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2024 financial results [...]

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

23/04/2024 - 22:05

TAMPA, FL, April 23, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. ( Nasdaq: MEDS ) (the “Company”), announced that, on April 17, 2024, the Company received a notice (the “Notice”) from the Nasdaq Listing Qualifications [...]

ClearPoint Neuro to Announce First Quarter 2024 Results May 7, 2024

23/04/2024 - 22:05

SOLANA BEACH, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine [...]

Seer to Report First Quarter 2024 Financial Results on May 8, 2024

23/04/2024 - 22:05

REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial [...]

Pennant Announces First Quarter 2024 Earnings Release and Call

23/04/2024 - 22:02

EAGLE, Idaho, April 23, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]

Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor

23/04/2024 - 21:56

First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or rearrangement, or BRAF V600 mutation RAPNO LGG overall response rate (ORR) of 51% Day One [...]

OrthoSelect announces Partnership with Relu to provide automated CBCT integration for DIBS AI software

23/04/2024 - 19:50

AMERICAN FORK, Utah, April 23, 2024 (GLOBE NEWSWIRE) -- OrthoSelect, a leading orthodontics software company and digital orthodontics laboratory, announces a partnership with Belgium-based Relu to integrate the award- [...]

Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors

23/04/2024 - 19:42

Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients Gastroenteropancreatic neuroendocrine tumors ( [...]

Grant of warrants

23/04/2024 - 19:20

23 April 2024 Announcement no. 9 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, April 23, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has [...]